Differential profile of activated regulatory T cell subsets and microRNAs in tolerant liver transplant recipients

Liver Transplantation

Volumn 23, Issue 7, 2017, Pages 933-945

  Revilla Nuin, Beatriz ^a   de Bejar, África ^b   Martínez Alarcón, Laura ^a   Herrero, José Ignacio ^c   Martínez Cáceres, Carlos Manuel ^a   Ramírez, Pablo ^a   Baroja Mazo, Alberto ^a   Pons, José Antonio ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO SANTA LUCÍA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCINEURIN INHIBITOR; CD31 ANTIGEN; CD45RA ANTIGEN; CYCLOSPORIN A; EVEROLIMUS; GENOMIC DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HELIOS PROTEIN; HLA DR ANTIGEN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IKAROS TRANSCRIPTION FACTOR; INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 2 RECEPTOR; LATENCY ASSOCIATED PEPTIDE; MICRORNA; MICRORNA 146A; MICRORNA 155; MICRORNA 24; MICRORNA 31; MICRORNA 95; MYCOPHENOLATE MOFETIL; PROTEIN; RAPAMYCIN; SMALL NUCLEAR RNA; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMETHYLATION; EFFECTOR CELL; EPIGENETICS; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GRAFT RECIPIENT; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER GRAFT; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T CELL SPECIFIC DEMETHYLATED REGION; REGULATORY T LYMPHOCYTE; RETROSPECTIVE STUDY; CLUSTER ANALYSIS; IMMUNOLOGY; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; TRANSPLANTATION TOLERANCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; DEMETHYLATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MICRORNAS; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 85021139554     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24691     Document Type: Article

References (39)

1. Pons JA, Revilla-Nuin B, Baroja-Mazo A, Ramirez P, Parrilla P. Regulatory T cells in transplantation. In: Chen H, Qian S, editors. Experimental Organ Transplantation. New York, NY: Nova Science Publisher, Inc.; 2013:389-420.
2. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and induced CD4+CD25 + cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 2004;172:5213-5221.
3. Yadav M, Louvet C, Davini D, Gardner JM, Martinez-Llordella M, Bailey-Bucktrout S, et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 2012;209:1713-1722.
4. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, Shevach EM. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3 + T regulatory cells. J Immunol 2010;184:3433-3441.
5. Spoerl S, Li XC. Regulatory T cells and the quest for transplant tolerance. Discov Med 2011;11:25-34.
6. Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, et al. Two functional subsets of FOXP3 + regulatory T cells in human thymus and periphery. Immunity 2008;28:870-880.
7. Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, et al. Epigenetic control of the FOXP3 locus in regulatory T cells. PLoS Biol 2007;5:e38.
8. Baron U, Floess S, Wieczorek G, Baumann K, Grützkau A, Dong J, et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007;37:2378-2389.
9. Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, Liebenberg V, et al. Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009;69:599-608.
10. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001;107:823-826.
11. Bi Y, Liu G, Yang R. MicroRNAs: novel regulators during the immune response. J Cell Physiol 2009;218:467-472.
12. Hoefig KP, Heissmeyer V. MicroRNAs grow up in the immune system. Curr Opin Immunol 2008;20:281-287.
13. Harris A, Krams SM, Martinez OM. MicroRNAs as immune regulators: implications for transplantation. Am J Transplant 2010;10:713-719.
14. Mas VR, Dumur CI, Scian MJ, Gehrau RC, Maluf DG. MicroRNAs as biomarkers in solid organ transplantation. Am J Transplant 2013;13:11-19.
15. Zhuo C, Li Z, Xu Y, Wang Y, Li Q, Peng J, et al. Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival. Mol Cancer 2014;13:153.
16. Nair VS, Oh KI. Down-regulation of Tet2 prevents TSDR demethylation in IL2 deficient regulatory T cells. Biochem Biophys Res Commun 2014;450:918-924.
17. Baroja-Mazo A, Revilla-Nuin B, Parrilla P, Martínez-Alarcón L, Ramírez P, Pons JA. Tolerance in liver transplantation: biomarkers and clinical relevance. World J Gastroenterol 2016;22:7676-7691.
18. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al. Functional delineation and differentiation dynamics of human CD4 + T cells expressing the FOXP3 transcription factor. Immunity 2009;30:899-911.
19. Benítez C, Londoño MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 2013;58:1824-1835.
20. de la Garza RG, Sarobe P, Merino J, Lasarte JJ, D'Avola D, Belsue V, et al. Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance. Liver Transpl 2013;19:937-944.
21. Pons JA, Revilla-Nuin B, Baroja-Mazo A, Ramírez P, Martínez-Alarcón L, Sánchez-Bueno F, et al. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation 2008;86:1370-1378.
22. Braza F, Dugast E, Panov I, Paul C, Vogt K, Pallier A, et al. Central role of CD45RA- Foxp3hi memory regulatory T cells in clinical kidney transplantation tolerance. J Am Soc Nephrol 2015;26:1795-1805.
23. Anderson MR, Enose-Akahata Y, Massoud R, Ngouth N, Tanaka Y, Oh U, Jacobson S. Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs. J Neuroimmune Pharmacol 2014;9:522-532.
24. Gandhi R, Anderson DE, Weiner HL. Cutting edge: immature human dendritic cells express latency-associated peptide and inhibit T cell activation in a TGF-beta-dependent manner. J Immunol 2007;178:4017-4021.
25. Tran DQ, Andersson J, Hardwick D, Bebris L, Illei GG, Shevach EM. Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3 + regulatory T cells allows for their purification from expansion cultures. Blood 2009;113:5125-5133.
26. Sugimoto N, Oida T, Hirota K, Nakamura K, Nomura T, Uchiyama T, Sakaguchi S. Foxp3-dependent and -independent molecules specific for CD25+CD4 + natural regulatory T cells revealed by DNA microarray analysis. Int Immunol 2006;18:1197-1209.
27. Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. Helios expression is a marker of T cell activation and proliferation. PloS one 2011;6:e24226.
28. Elkord E, Abd Al Samid M, Chaudhary B. Helios, and not FOXP3, is the marker of activated Tregs expressing GARP/LAP. Oncotarget 2015;6:20026-20036.
29. Beier KC, Hutloff A, Dittrich AM, Heuck C, Rauch A, Büchner K, et al. Induction, binding specificity and function of human ICOS. Eur J Immunol 2000;30:3707-3717.
30. Burmeister Y, Lischke T, Dahler AC, Mages HW, Lam KP, Coyle AJ, et al. ICOS controls the pool size of effector-memory and regulatory T cells. J Immunol 2008;180:774-782.
31. Yamamoto M, Kondo E, Takeuchi M, Harashima A, Otani T, Tsuji-Takayama K, et al. miR-155, a Modulator of FOXO3a protein expression, is underexpressed and cannot be upregulated by stimulation of HOZOT, a line of multifunctional Treg. PLoS One 2011;6:e16841.
32. Kohlhaas S, Garden OA, Scudamore C, Turner M, Okkenhaug K, Vigorito E Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol 2009;182:2578-2582.
33. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010;142:914-929.
34. Morita M, Chen J, Fujino M, Kitazawa Y, Sugioka A, Zhong L, Li XK. Identification of microRNAs involved in acute rejection and spontaneous tolerance in murine hepatic allografts. Sci Rep 2014;4:6649.
35. Fayyad-Kazan H, Rouas R, Fayyad-Kazan M, Badran R, El Zein N, Lewalle P, et al. MicroRNA profile of circulating CD4-positive regulatory T cells in human adults and impact of differentially expressed microRNAs on expression of two genes essential to their function. J Biol Chem 2012;287:9910-9922.
36. Rouas R, Fayyad-Kazan H, El Zein N, Lewalle P, Rothé F, Simion A, et al. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 2009;39:1608-1618.
37. Danger R, Pallier A, Giral M, Martínez-Llordella M, Lozano JJ, Degauque N, et al. Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. J Am Soc Nephrol 2012;23:597-606.
38. Lozano JJ, Pallier A, Martinez-Llordella M, Danger R, López M, Giral M, et al. Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant 2011;11:1916-1926.
39. Londoño MC, Danger R, Giral M, Soulillou JP, Sánchez-Fueyo A, Brouard S. A need for biomarkers of operational tolerance in liver and kidney transplantation. Am J Transplant 2012;12:1370-1377.